Skip to main content
SpringerLink
Log in

Forum

Updates in Pharmaceutical Medicine

  • Update
  • Published:
International Journal of Pharmaceutical Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Guiding principles. Processing Joint FDA EMEA Voluntary Genomic Data Submissions (VGDSs) within the framework of the Confidentiality Arrangement. Available from URL: http://www.emea.eu.int/pdfs/general/direct/pr/FDAEMEA.pdf.

  2. The EUREKA Initiative aims to strengthen European competitiveness by promoting cross-border, market-oriented, collaborative R&D. It enables industry and research institutes from 35 member countries and the EU to collaborate in a bottom-up approach to developing and exploiting innovative technologies.

  3. Draft Regulation of the European Parliament and of the Council on medicinal products for paediatric use and amending Regulation (EEC) No. 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No. 726/2004.

References

Reference

  • Academy of Pharmaceutical Physicians & Investigators. Four physicians receive awards for outstanding contributions to pharmaceutical medicine and clinical research. Media release: 1 May 2006

    Google Scholar 

Reference

  • European Medicines Agency. Public Statement; EU (European Commission and EMEA) and FDA agree on guiding principles for joint FDA EMEA voluntary genomic data submission briefing meetings [online]. Available from URL: http://www.emea.eu.int [Accessed 2 Jun 2006]

    Google Scholar 

Reference

  1. World Health Organization. The World Health Organization announces new standards for registration of all human medical research. Media release: 19 May 2006

    Google Scholar 

  2. International Federation of Pharmaceutical Manufacturers & Associations. Pharmaceutical industry supports move towards increased clinical trial transparency to help doctors and patients to facilitate informed treatment choices. Media release: 18 May 2006

    Google Scholar 

Reference

  1. Eureka. Turning the tables on drug discovery [online]. Available from URL: http://www.eureka.be/inaction/viewSuccessStory.do?docid=1719838 [Accessed 30 May 2006]

    Google Scholar 

  2. Eureka. Turning the tables on drug discovery. Media release: 24 May 2006

    Google Scholar 

Reference

  1. Federal Register 2006: 71 (90): 27264-27266

  2. European Federation of Pharmaceutical Industries and Associations. EFPIA welcomes today’s European parliament vote on medicines for children use. Media release: 1 Jun 2006

    Google Scholar 

  3. Medicines and Healthcare Products Regulatory Agency. Medicines for children. Media release: 1 Jun 2006

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Forum. Int J Pharm Med 20, 197–200 (2006). https://doi.org/10.2165/00124363-200620030-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00124363-200620030-00006

Keywords

Search

Navigation